Search Results

Site Search

https://www.mayocliniclabs.com/test-catalog/pdf-reports.php

MCL PDF Reports Values current as of June 2, 2025 Mayo Test ID Published Name PDF 2OHGP 2-Hydroxyglutaric Aciduria Gene Panel, Varies Supplemental 3MGAP 3-Methylglutaconic Aciduria Panel, Varies Supplemental ADPKP Focused Autosomal...

Direct immunofluorescence for autoimmune bullous diseases - Insights

In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.

CPT codes and LOINC update: May 2023 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of May.

Lab discoveries fuel updates for autoimmune movement disorders test - Insights

Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...

Lyme Disease Part 1: The Common Culprits Worldwide-Borrelia burgdorferi, Borrelia garinii, Borrelia afzelii - Insights

In this “Hot Topic,” Elitza Theel, Ph.D., discusses how common cases of presumed Lyme disease go unreported each year and discusses scenarios in which testing for Lyme disease is indicated and reviews both recommended and inappropriate...

MCL Autoimmune Axonal Neuropathy A Comprehensive Testing Approach MC2775425

MCL Autoimmune Axonal Neuropathy Comprehensive Testing Approach NEUROLOGY AUTOIMMUNE AXONAL NEUROPATHY COMPREHENSIVE TESTING APPROACH Patients neuropathy variable sensory motor disturbance loss exaggerated

MCLRequest for Supplies MC0748

MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date

Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights

Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights

In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...

Rare patient case helps inform and validate GABA-A-R antibody encephalitis testing: JoAnne Michael - Insights

JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...

Rare patient case helps inform and validate GABA-A-R antibody encephalitis testing: JoAnne Michael - Insights

JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...

New Tests Launched in August - Insights

In August 2020, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in September - Insights

In September 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in April - Insights

In April 2020, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in January - Insights

In January 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in October - Insights

In October 2018, Mayo Medical Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in January - Insights

In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Testing Archives - Page 26 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Drawing the Line: The Rationale Behind Blood Tube Collection Order - Insights

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Brooke Katzman, Ph.D., to discuss the blood tube collection order.

New Tests Launched in June - Insights

In June 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in February - Insights

In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in October - Insights

In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in June - Insights

In June 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in September - Insights

In September 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes. In addition to these new tests, the department also announced several test changes.

Insect-borne disease - Insights

Find out more about our targeted approach to testing for the various diseases carried by a number of different insect species.

New Tests Launched in December - Insights

In December 2017, Mayo Medical Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in February - Insights

In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in August - Insights

In August 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Pathways Case Studies: June 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Gastroenterology Pathology,...

Pathways Case Studies: February 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Clinical Biochemistry, Bone and...

Understanding Membranoproliferative Glomerulonephritis, Including C3 Glomerulopathy: Part 1 - Insights

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...

Oncology surveillance biomarker study enrolls patients and evaluates assay - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company...

CPT codes and LOINC update: November 2023 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of November.

Using Statin Choice Decision-Aid Tool and Laboratory Testing to Reduce Cardiac Risk - Insights

With more than 70,000 uses worldwide and policy endorsements for its use (JAMA Article), the Mayo Clinic Statin Choice Decision-Aid tool is helping patients and their clinicians have meaningful conversations about whether or not to use...

Leslie Donato, Ph.D., Discusses New Lab Testing Options to Evaluate IBS-D Patients - Insights

Leslie Donato, Ph.D., Consultant in Cardiovascular Laboratory Medicine and Clinical Core Laboratory at Mayo Clinic, recently authored an article in "Medical Lab Management" on new laboratory testing options to evaluate irritable bowel...

Other Testing - Insights

Mayo Clinic physicians and scientists drive research and test development, and our assays are backed by some of the world’s leading subspecialists.

Ganglioside-associated neuropathies - Insights

Learn how Mayo Clinic Laboratories’ ganglioside antibody evaluation can provide diagnostic clarity and a path forward for patients impacted by autoimmune peripheral neuropathy.

Tick Season Outlook: Elitza Theel, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...

The Latest on Measles: Matthew Binnicker, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo...

Autoimmune GI Dysmotility - Mayo Clinic Laboratories

Identifying GI dysmotility as autoimmune-mediated is extremely important because patients treated with immunotherapy can see a dramatic improvement, going from persistent nausea, vomiting, and weight loss to feeling normal within a few...

Creatine disorders - Insights

Check out Mayo Clinic Laboratories’ biochemical and molecular testing options to diagnose creatine deficiency disorders.

MCL - Hematopathology/Cytogenetics Test Request Form T726 - MC0767-05A

MCL - Hematopathology/Cytogenetics Test Request Form T726

Top Gun Phlebotomy - Butterfly Use: The Good, the Bad, and the Ugly - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will discuss recent information on the advantages and disadvantages of using butterfly needles for blood collection.

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Insights

In this month's "Hot Topic," Eoin Flanagan, M.B., B.Ch., reviews the recent diagnostic criteria for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD).

Gadolinium Accumulation in Brain Tissue following Contrast-Enhanced MRI Has Not Been Shown to Have Harmful Side Effects - Insights

Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...

Clinical Laboratory News Recaps Dr. Melissa Snyder's AACC Short Course on Monoclonal Antibody Therapeutics - Insights

At the recent AACC annual scientific meeting, Melissa Snyder, Ph.D., Consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, presented the short course, “Clinical and Laboratory Aspects of...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.

Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights

This week's research roundup feature: Measles virus (MV) vaccine strains have shown significant preclinical antitumor activity against glioblastoma (GBM), the most lethal glioma histology. In this first in human trial (NCT00390299), a...

Mayo Clinic Laboratory and pathology research roundup: April 11 - Insights

This week's Research Roundup feature: A stress-induced cilium-to-PML-NB route drives senescence initiation.

Mayo Clinic Laboratory and pathology research roundup: June 14 - Insights

Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.